Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Kuznar-Kaminska, J. Mikula-Pietrasik, K. Ksiazek, H. Batura-Gabryel (Poznan, Poland). Chemokines CXCL12 and CCL21 may contribute to the development of lung cancer in COPD patients. Eur Respir J 2013; 42: Suppl. 57, 553

Member's Comments

No comment yet.

Related content which might interest you: Increased expression of a proliferation-inducing ligand (APRIL) in lung leukocytes and alveolar epithelial cells in COPD patients with non small cell lung cancer: A possible link between COPD and lung cancer? Source: International Congress 2016 – Mechanisms of disease Year: 2016 Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 The impact of chronic obstructive pulmonary disease on survival of the patients with small-cell lung cancer Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 Osteopontin levels in sputum supernatant and serum of patients with lung cancer: Does coexistent COPD make the difference? Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013 Increased sirtuin expression in patient with lung squamous cell carcinoma co-morbid with COPD Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Prognostic affect of the chronic obstructive pulmonary disease on the local-advanced stage non-small cell lung cancer Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Serum osteopontin as a prognostic marker in patients with lung cancer Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 COPD and lung cancer: Prevalence, infradiagnosis, phenotypes and multidimensional characterization Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer Year: 2016 Advanced lung cancer inflammation index (ALI): A new pronostic score in patients with non small cell lung cancer Source: International Congress 2016 – Lung cancer and immune cells: friends or foes? Year: 2016 The impact of pulmonary rehabilitation on preoperative inflammatory markers in lung cancer patients Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts Year: 2013 Prevalence of COPD and emphysema at the time of diagnosis of primary lung cancer Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 DNA methylation profiling of non-small cell lung cancer reveals an immune signature in COPD patients Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome) Year: 2013 Lymphocyte profile in the BALF from affected lung in comparison to healthy lung and systemic inflammation in lung cancer Source: International Congress 2016 – Lung cancer and immune cells: friends or foes? Year: 2016 Epigenetic alterations in the circulating DNA from blood of patients with COPD and lung cancer Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making Year: 2013 IL-17C promotes tumor-associated inflammation and lung tumor growth Source: International Congress 2016 – Late-breaking translational research in lung cancer Year: 2016 Stereotactic body radiation does not impair respiratory health in patients with stage I non-small cell lung cancer Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts Year: 2013 Surfactant protein-D level as a predictor of prognosis of interstitial lung disease induced by anticancer agents in advanced lung cancer Source: International Congress 2016 – Orphan diseases I Year: 2016 Weight loss cutoff level as a key variable related to death risk among advanced lung cancer patients Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Incidence of interstitial lung disease (ILD) and risk factors for developing ILD: A final analysis of a large-scale erlotinib Japanese surveillance study in non-small-cell lung cancer (NSCLC) Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Lung diseases infection and risk of lung cancer Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013